Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)
NCT02245503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7391
Last updated 2014-09-19
Summary
The objectives of this post marketing surveillance study were to document the comorbidity and comedication during prescription of ALNA® (Tamsulosin) for patients with BPH (Benign Prostatic Hyperplasia).
Conditions
- Prostatic Hyperplasia
Interventions
- DRUG
-
Tamsulosin
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-05-31
- Primary Completion
- 2003-10-31
More Related Trials
-
Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms
NCT02715024 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
NCT00510406 ·Status: COMPLETED ·Phase: PHASE2
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms
NCT02245490 ·Status: COMPLETED ·Phase: PHASE4
-
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
NCT01736033 ·Status: UNKNOWN ·Phase: PHASE4
-
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
NCT00090103 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients
NCT02244229 ·Status: COMPLETED ·Phase: PHASE4
-
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.
NCT02417844 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System
NCT06965582 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Benign Prostatic Hyperplasia in Taiwan
NCT00941343 ·Status: COMPLETED ·Phase: NA
-
ALF-ONE : ALFuzosin ONcE Daily
NCT00280605 ·Status: COMPLETED ·Phase: PHASE4
-
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
NCT00701779 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
NCT01673490 ·Status: TERMINATED ·Phase: PHASE4
-
A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.
NCT00379067 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
NCT00540891 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
NCT01457573 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS
NCT01589263 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
NCT01021332 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial in Males With BPH (Enlarged Prostate)
NCT00029822 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia
NCT06689514 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms
NCT01018511 ·Status: COMPLETED ·Phase: PHASE3
-
Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT06051383 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation
NCT02180789 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study
NCT06809205 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
NCT00347061 ·Status: COMPLETED ·Phase: PHASE3